¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"afferent pathways"¿¡ ´ëÇÑ °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç »çÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • C afferent
    C ±¸½É ½Å°æ
    °¡´Â ½Å°æ ¼¶À¯. Àü´Þ ¼Óµµ°¡ ºü¸£°í ÅëÁõÀ» Àü´ÞÇÑ´Ù.
  • C primary afferent nociceptor
    C ÀÏÂ÷ ±¸½É¼º Ä§ÇØ ¼ö¿ëü, C ÀÏÂ÷ ±¸½É¼º À¯ÇØ ¼ö¿ë±â
  • converging afferent interneuron
    ÁýÇÕ¼º ±¸½É¼º °³Àç ´º·±
  • cutaneous afferent
    ÇǺΠ±¸½É ½Å°æ
  • inhibitory afferent input
    ¾ïÁ¦¼º ±¸½É¼º ÀÔ·Â
  • myelinated afferent
    À¯¼öÃÊ ±¸½É ½Å°æ
  • myelinated afferent inhibition
    À¯¼öÃÊ ±¸½É¼º ¾ïÁ¦
  • myelinated cutaneous afferent
    À¯¼öÃÊ ÇǺΠ±¸½É ½Å°æ
  • myelinated non-nociceptive afferent
    À¯¼öÃÊ ºñÄ§ÇØ¼ö¿ë¼º ±¸½É ½Å°æ, À¯¼öÃÊ ºñÀ¯Çؼö¿ë¼º ±¸½É ½Å°æ
  • myelinated primary afferent
    ÀÏÂ÷ À¯¼öÃÊ ±¸½É ½Å°æ
  • nociceptive afferent input
    Ä§ÇØ ¼ö¿ë¼º ±¸½É ÀÔ·Â, À¯ÇØ ¼ö¿ë¼º ±¸½É ÀÔ·Â
  • nociceptive primary afferent
    Ä§ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ½Å°æ, À¯ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ½Å°æ
  • non-nociceptive A delta C primary afferent
    ºñÄ§ÇØ ¼ö¿ë¼º A µ¨Å¸ C ÀÏÂ÷ ±¸½É ½Å°æ, ºñÀ¯ÇØ ¼ö¿ë¼º A µ¨Å¸ C ÀÏÂ÷ ±¸½É ½Å°æ
  • non-nociceptive myelinated afferent
    ºñÄ§ÇØ ¼ö¿ë¼º À¯¼ö ±¸½É ¼¶À¯, ºñÀ¯ÇØ ¼ö¿ë¼º À¯¼ö ±¸½É ¼¶À¯
  • non-nociceptive myelinated primary afferent
    ºñÄ§ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ¼¶À¯, ºñÀ¯ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ¼¶À¯
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
ÅëÇÕ°Ë»ö ¿Ï·á